RxDoctor Payments Data

Selvon St Clair, MD

Orthopaedic Surgery of the Spine · Lima, OHNPI 1558533083

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $108,265 of the $167,982 with a category attached, or 64.5%. 19 manufacturers reported payments, led by CTL Medical Corporation at 57.8% of the total. Reporting peaked in 2021 at $52,741 and has fallen 64.7% since, to $18,636 in 2025.

$167,982in general payments, 2019–2025

Across 137 payments — averaging $1226.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CTL Medical Corporation$97K
  • Surgalign Spine Technologies, Inc.$49K
  • Xtant Medical Inc$12K
  • Kuros Biosciences USA, Inc$8K
  • Stryker$534
  • Alphatec Spine, Inc$361
  • plus $979 from 13 others

What the payments were for

  • Royalty or licence$108,26564%
  • Consulting fees$46,71728%
  • Travel & lodging$10,0056%
  • Food & beverage$2,9762%
  • Education$100%
  • Gifts$100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$167,982 in reported general payments places this provider in the 85th percentile of 64 orthopaedic surgery of the spine providers in Ohio.

See all orthopaedic surgery of the spine providers in Ohio

Medicare billing

Part B allowed, 2024
$376,920
Medicare patients
412
Services billed
2,257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone102$619
Gabapentin60$529
Cyclobenzaprine Hcl56$461
Meloxicam44$154
Cephalexin16$56

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →